1. Remdesivir to cost $3120 for typical COVID-19 treatment: Report  Yahoo Finance
  2. Remdesivir, the first coronavirus drug, gets a price tag  ABS-CBN News
  3. Here's how much COVID-19 drug remdesivir will cost  CNN Philippines
  4. Gilead Sets a Good-Enough Bar With Covid-Treatment Price  Bloomberg
  5. Dr. Marc Siegel: Coronavirus defense — as numbers rise, promising drug Remdesivir cleared for use  Fox News
  6. View Full coverage on Google News
The price potentially reflects looming competition from dexamethasone, a cheap drug hailed as a potential breakthrough treatment.The price potentially reflects looming competition from dexamethasone, a cheap drug hailed as a potential breakthrough treatment.

Gilead prices Covid-19 drug candidate remdesivir at $2,340 per patient - World - DAWN.COM

New York: Gilead Sciences has said it will charge governments $2,340 for a 5-day course of remdesivir, a drug that has been shown to shorten recovery times in Covid-19 patients, Financial Times...New York: Gilead Sciences has said it will charge governments $2,340 for a 5-day course of remdesivir, a drug that has been shown to shorten recovery times in Covid-19 patients, Financial Times...

Gilead to charge $2,340 for Covid-19 treatment remdesivir

Remdesivir is expected to be in high demand as one of the only treatments shown to alter the course of COVID-19Remdesivir is expected to be in high demand as one of the only treatments shown to alter the course of COVID-19

Gilead sets coronavirus drug candidate remdesivir at $2,340 per patient

Bloomberg - Are you a robot?

Preliminary trial results demonstrated that Remdesivir decreased the duration of illness and had an impact on the death rate.Preliminary trial results demonstrated that Remdesivir decreased the duration of illness and had an impact on the death rate.

Gilead Sciences said Monday it will charge $2,340 for usual treatment of remdesivir, a drug that is used to shorten recovery time for severely ill COVID-19 patients. However, critics have called the price “an outrage” because of the amount taxpayers invested toward its development.Gilead Sciences said Monday it will charge $2,340 for usual treatment of remdesivir, a drug that is used to shorten recovery time for severely ill COVID-19 patients. However, critics have called the price “an outrage” because of the amount taxpayers invested toward its development.

COVID-19 Drug to Cost $2340

Gilead Sciences has set the price of its investigational Covid-19 drug remdesivir at $390 per vial for the US and governments of other developed countries.Gilead Sciences has set the price of its investigational Covid-19 drug remdesivir at $390 per vial for the US and governments of other developed countries.

Gilead sets Covid-19 drug candidate remdesivir price at $390 per vial

More than 10 million people worldwide have been infected with the coronavirus as of Monday, with over half a million dead as the U.S. struggled to contain a spike in infections.More than 10 million people worldwide have been infected with the coronavirus as of Monday, with over half a million dead as the U.S. struggled to contain a spike in infections.

Coronavirus update: Global infections tops 10M; Gilead sets eye-popping remdesivir price

Supply expected over coming months, priced at $3,120 for privately insured patientsSupply expected over coming months, priced at $3,120 for privately insured patients

U.S. to Secure Enough Remdesivir for Half a Million COVID Patients | MedPage Today

The UK death toll from coronavirus has risen to 43,575, the government said on Monday. The Department of Health and Social Care (DHSC) also said in the 24-hour period up to 9am on Monday, 93,881 tests have been carried out or dispatched, with 815 positive results.The UK death toll from coronavirus has risen to 43,575, the government said on Monday. The Department of Health and Social Care (DHSC) also said in the 24-hour period up to 9am on Monday, 93,881

UK coronavirus deaths rise by 25 to 43,575 | The Independent

Remdesivir, the first drug shown to be effective against the coronavirus, will be distributed under an unusual agreement with the federal government that establishes nonnegotiable prices and prioritizes American patients, health officials announced Monday. The arrangement may serve as a template for the distribution of new treatments and vaccines as the pandemic swells, saidRemdesivir, the first drug shown to be effective against the coronavirus, will be distributed under an unusual agreement with the federal government that establishes nonnegotiable prices and

First coronavirus drug Remdesivir gets a price tag | Deccan Herald

Gilead Sciences has addressed the big question surrounding just how much its drug remdesivir will cost for COVID-19 treatment, after positive early trialsGilead Sciences has addressed the big question surrounding just how much its drug remdesivir will cost for COVID-19 treatment, after positive early trials indicated the medicine could hasten recove…

Gilead CEO answers big COVID-19 question: How much will remdesivir cost - SlashGear

The shortage of the drug in India gave rise to a grey market. The shortage of the drug in India gave rise to a grey market.

COVID-19: Scrambling for unavailable Remdesivir, desperate patients in India turned to Bangladesh

An Open Letter from Daniel O’Day, Chairman & CEO, Gilead Sciences

All the latest news, views and campaigns for Sydney and NSW.

We’re for Sydney | Daily Telegraph

Shares of Gilead Sciences Inc. undefined gained 1.1% in premarket trading on Monday after the drugmaker disclosed that remdesivir, its experimental COVID-19...Shares of Gilead Sciences Inc. undefined gained 1.1% in premarket trading on Monday after the drugmaker disclosed that remdesivir, its experimental COVID-19...

Gilead prices remdesivir at $2,340 for treatment in most of the developed world - MarketWatch

Gilead Sciences has announced the pricing for its Covid-19 drug remdesivir. The company will charge governments in developed countries, including the United States, $390 a vial, or $2,340 for a typical five-day treatment course using six vials of the drug. A longer course of treatment would cost $4,290Gilead Sciences has announced the pricing for its Covid-19 drug remdesivir. The company will charge governments in developed countries, including the United States, $390 a vial, or $2,340 for a typical five-day treatment course using six vials of the drug. A longer course of treatment would cost $4,290

Covid-19 Drug Remdesivir Gets Long-Awaited Price

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

THE first antiviral drug shown to effectively treat Covid-19 will cost patients more than $3,000 from this week. A typical patient with private insurance at a U.S. hospital will have to pay thousan…

Coronavirus drug remdesivir to cost more than $3,000 from THIS WEEK for ‘typical patient on private insurance’ – The Sun

Remdesivir’s price has been highly anticipated since it became the first medicine to show benefit in the pandemic, which has killed more than 500,000 people.A consumer group called the set price for remdesivir 'an outrage' because of the amount taxpayers invested toward the drug's development.

COVID-19 drug candidate remdesivir priced at $2,340 per patient | kgw.com

Gilead Sciences, the pharmaceutical company behind the COVID-19 drug remdesivir, just announced how much it plans to charge for the antiviral medication.Gilead Sciences, the pharmaceutical company behind the COVID-19 drug remdesivir, just announced how much it plans to charge for the antiviral medication.

Even With Insurance, the COVID Drug Remdesivir Is Shockingly Expensive

Gilead Sciences, the pharmaceutical company behind the COVID-19 drug remdesivir, just announced how much it plans to charge for the antiviral medication.Gilead Sciences, the pharmaceutical company behind the COVID-19 drug remdesivir, just announced how much it plans to charge for the antiviral medication.

Even With Insurance, the COVID Drug Remdesivir Is Shockingly Expensive

One of the companies pushing forward with a coronavirus treatment has announced how much it will cost for patients.One of the companies pushing forward with a coronavirus treatment has announced how much it will cost for patients.

Coronavirus: Remdesivir treatment comes with $3,120 price tag for patients with private insurance

Gilead Sciences Inc. says its experimental anti-coronavirus drug remdesivir will be supplied to the governments of developed countries at what it sees as an affordable price of $2,340 per patient for a typical five-day treatment course.Gilead Sciences Inc. says its experimental anti-coronavirus drug remdesivir will be supplied to the governments of developed countries at what it sees as an affordable price of $2,340 per patient for a typical five-day treatment course.

Coronavirus treatment with remdesivir to cost $2,340 per patient

The treatment will cost $3,120 for a five-day treatment course for a patient with private insurance in the U.S.The treatment will cost $3,120 for a five-day treatment course for a patient with private insurance in the U.S.

Gilead names remdesivir price - Commercial - MM&M - Medical Marketing and Media

404 Not Found

(Reuters Breakingviews) - Medicine may be a science but drug pricing is definitely an art. That’s especially true of Gilead Sciences’ treatment for Covid-19, given the lack of alternative treatments for a pandemic. The $2,300 price of a course of remdesivir may sound high – and is compared with the basic cost of manufacturing the stuff – but is actually fairly restrained.(Reuters Breakingviews) - Medicine may be a science but drug pricing is definitely an art. That’s especially true of Gilead Sciences’ treatment for Covid-19, given the lack of alternative treatments for a pandemic. The $2,300 price of a course of remdesivir may sound high – and is compared with the basic cost of manufacturing the stuff – but is actually fairly restrained.

Breakingviews - Gilead gives glimpse into feverish drug market - Reuters

Gilead Sciences on Monday disclosed its pricing for remdesivir, its coronavirus-fighting drug.  Shares of the company jumped as much as 4% ... Gilead Sciences on Monday disclosed its pricing for remdesivir, its coronavirus-fighting drug.  Shares of the company jumped as much as 4% ...

Gilead rises after pricing its coronavirus-fighting drug remdesivir (GILD) | Markets Insider

Gilead will begin charging U.S. patients for the experimental COVID-19 drug remdesivir in two weeks, the company and the government announced Monday, as cases surge and hospitalizations reach crisis levels in several states.Gilead will begin charging U.S. patients for the experimental COVID-19 drug remdesivir in two weeks, the company and the government announced Monday, as cases surge and hospitalizations reach crisis levels in several states.

Facebook

Yes, the same company behind Truvada.Yes, the same company behind Truvada.

US drug maker says its coronavirus medication will cost up to 5,700 per treatmentUS drug maker says its coronavirus medication will cost up to 5,700 per treatment

US drug maker says its coronavirus medication will cost up to $5,700 per treatment — RT Business News

Access to this page has been denied.

Drugmaker Gilead wants you to believe it's doing you a favor by setting the insured price for its pending COVID-19 treatment, remdesivir, at more than $3,000.The drug maker says its high price for remdesivir is warranted because hospitalization would cost thousands of dollars more.

Is Gilead a rip off with COVID-19 treatment topping $3,000? - Los Angeles Times

"Taxpayers provided funding for the development of this drug. Now Gilead is price-gouging off it during a pandemic. Beyond disgusting," said Sen. Bernie Sanders."Taxpayers provided funding for the development of this drug. Now Gilead is price-gouging off it during a pandemic. Beyond disgusting," said Sen. Bernie Sanders.

'Absolute Robbery': Gilead Announces $3,120 Price Tag for Covid-19 Drug Developed With $70 Million in Taxpayer Support | Common Dreams News

“The bad news is that the pricing is remarkably low, given the direct medical value, not to mention the societal value,” said analyst Geoffrey Porges“The bad news is that the pricing is remarkably low, given the direct medical value, not to mention the societal value,” said analyst Geoffrey Porges

Gilead's resmdesivir pricing raises questions about long-term prospects

A typical patient on private insurance can expect to pay $3,120 per course of treatment for the Covid-19 drug.A typical patient on private insurance can expect to pay $3,120 per course of treatment for the Covid-19 drug.

Gilead Finally Reveals Remdesivir Pricing After Weeks Of Speculation

Remdesivir is at the forefront of the fight against COVID-19 after it helped shorten hospital recovery times in a trial.Remdesivir is at the forefront of the fight against COVID-19 after it helped shorten hospital recovery times in a trial.

Gilead prices COVID-19 drug remdesivir, faces competition | USA News | Al Jazeera

Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.

Gilead Science releases pricing plan for COVID-19 drug Remdesivir | One America News Network

Industry watchers and pharma critics have spent the past two months pitching their calculations on how Gilead Sciences would—and should—price remdesivir. Now, the guessing is over. And the finalized price means Gilead could still reap $2.3 billion in 2020 revenue from remdesivir, one analyst figures.Industry watchers and pharma critics have spent the past two months pitching their calculations on how Gilead Sciences would—and should—price remdesivir. Now, the guessing is over. And the finalized price means Gilead could still reap $2.3 billion in 2020 revenue from remdesivir, one analyst figures.

Gilead's long-awaited remdesivir price is $3,120, in line with watchdog estimates | FiercePharma

Drugmaker Gilead Sciences announced on Monday its antiviral drug remdesivir, touted as a potential treatment for COVID-19, will set patients back by as much as $3,120...Drugmaker Gilead Sciences announced on Monday its antiviral drug remdesivir, touted as a potential treatment for COVID-19, will set patients back by as much as $3,120...

Gilead Plans to Charge Over $3,000 for COVID-19 Antiviral Remdesivir - Sputnik International